In the investor community, it matters what happens to these 200+ patients. What I said was with regard to the collection of scientific data beyond just the endpoint mortality or discharge numbers. It is in a foreign country; but perhaps Cytodyn in giving these vials for free can request that the hospital collect more info on the specific nature of patient progress. That can prove to be important: knowledge is power.